Cannabis Law Report

SEPTEMBER 14, 2021

Those insights will help bring products to market that are specifically formulated based on rigorous evidence to address need states like chronic pain, restful sleep, and general health and well-being. “By Step four: Brands select packaging, labels and other physical concepts for the selected product in a fully customizable experience.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Veriheal

OCTOBER 3, 2022

With the growing acceptance and legalization of cannabis, the pharmaceutical industry is taking serious hits, according to a 2022 novel study into the impact of cannabis legalization on pharmaceutical firms. What Is the Pharmaceutical Industry? pharmaceuticals). Still, most pharmaceuticals are heavily processed.

Pharmaceutical 104

Pharmaceutical Patients Research and Development Legalization 104

Kind Meds (Cannabis Education Blog)

FEBRUARY 24, 2022

In reality, people using marijuana during this time may have been self-medicating for a mental condition, choosing to use a different coping mechanism than the pharmaceuticals available at the time, pursuing better sleep, or simply enjoying a nontraditional method of increasing productivity and creativity. Do I Have to Smoke Cannabis?

Marijuana 52

Marijuana Research and Development Sleep Strains 52

The Cannigma

JUNE 15, 2021

However, the scientific data on CBG is nowhere near as developed as what we have on CBD. For now, if you have access to quality CBD products, there’s no reason to prioritize CBG products. Easy access. Many people use CBD to help them sleep, relieve anxiety, or both. Sonya Yruel/Drug Policy Alliance).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Info

MARCH 2, 2019

Cannabis is being viewed as a potential treatment for epileptic seizures and large success has been witnessed so far, triggering a large movement of people and organisations who are in favour of its access and medicinal use. ” CBD may be easier for patients to access when they opt to start treatment with medical cannabis.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

SEPTEMBER 2, 2022

The pharmaceutical industry takes a serious economic hit after states legalize marijuana—with an average market loss of nearly $10 billion for drugmakers per each legalization event—according to a first-of-its-kind study. By expanding access and, thus use, legalization could permit cannabis to compete with conventional pharmaceuticals.

Pharmaceutical 52

Pharmaceutical Legalization Marijuana Data 52

Veriheal

SEPTEMBER 23, 2021

Note: Veriheal does not support illegally consuming therapeutic substances such as Iboga but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Treatment 98

Treatment Medicine Research and Development Therapy 98

Project CBD

MAY 3, 2023

And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. It was highly rated for anxiety, pain, depression, and sleep problems. Remember, the pharmaceutical model is “this medicine addresses this specific target.”

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Cannabis Law Report

JANUARY 9, 2019

Phoenix, headquartered in Denver, distributes medicinal cannabis products around the globe to treat seven major categories of medical conditions including pain, cancer, autoimmune, metabolic, neurological, psychological and sleep disorders. The biggest pushback Phoenix has received until now has been the lack of data, Tindall said.

Therapy 85

Therapy Clinical Trials Treatment Medicine 85

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. At the same time, the outlook on cannabis research data is largely positive. Refractory paediatric epilepsy.

Research and Development 52

Research and Development Medicine Access Media 52

SMPL

MAY 26, 2020

And because CBD doesn’t get you high, it was easy to miss; hardly anyone outside of pharmaceutical companies and academia had heard of it. In the absence of oversight, the push to get more patients access to cannabis medicine — and bona fide CBD — has been co-opted by a push to make as much money as possible off the next big wellness fad. “At

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

The Cannigma

NOVEMBER 23, 2021

There is also a lack of access to healthcare professionals, and experts in the field, to guide patients through this complicated process. The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. Music by Desca. EG: For sure. Let’s listen.

Data 52

Data Patients Access Wellness and Beauty 52

CannaTech

FEBRUARY 25, 2019

Kanabo’s proprietary medical cannabis extracts focus on sleep disorders and post-traumatic stress disorder, and are specially formulated for vaporization with the medically certified VapePod vaporizer platform. Indorz : Indoor cannabis farming data solution that predicts, analyzes, and automates the grow process to maximize yield and quality.

Research and Development 85

Research and Development Hybrid Treatment Strains 85

The Cannigma

FEBRUARY 3, 2022

Let’s go ahead and dive right in on this one if you’re cool with it and then for the listeners, if you want to hang around afterwards, we have a segment from Americans for Safe Access here on the podcast and they share some useful insights every week so be sure to listen when we’re done. EG: All right, let’s listen to Dr. Bone. INTERVIEW].

Wellness and Beauty 109

Wellness and Beauty Patients Medicine Cannabis 109

The Cannigma

DECEMBER 22, 2021

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. Music by Desca. I won’t do too many spoilers here.

Research and Development 79

Research and Development Oil Cannabis Clinical Trials 79

Cannabis Law Report

OCTOBER 12, 2021

Diamandis joins Radicle Science as the healthtech company accelerates growth with industry veteran Sheldon Borkin PhD as CTO, the launch of a first of its kind real-world sleep study, and updates on significant milestones this year. Radicle Real World Sleep results will be announced in early 2022. “We

Clinical Trials 52

Clinical Trials Research and Development Sleep Cannabinoids 52

Cannabis Law Report

DECEMBER 7, 2021

The four-week Institutional Review Board (IRB) approved randomized controlled trial (RCT) of nearly 3,000 participants assigned to different botanical products containing CBD revealed significant improvement across all five health outcomes studied: well-being, quality of life, longer-term pain, feelings of anxiety, and sleep quality.

Clinical Trials 52

Clinical Trials CBD Data Sleep 52

The Cannigma

JANUARY 19, 2022

She explains how the state legislature in New York prevented her from accessing the medication she needed, as well as how difficult it was navigating the world of medical cannabis and finding a product that reliably worked for her. The Cannabis Enigma is a co-production of The Cannigma and Americans for Safe Access. Music by Desca.

Patients 83

Patients Compliance Compliance Cannabis 83

Cannabis Law Report

JUNE 4, 2021

David John Nutt is an English neuropsychopharmacologist specialising in the research of drugs that affect the brain and conditions such as addiction, anxiety, and sleep. Jonathan is the CEO and founder of Gilgamesh Pharmaceuticals. Lucia started her career advising pharmaceutical companies in investment banking. Drug Science.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51

Cannabis Law Report

SEPTEMBER 22, 2019

Knowing Your Rights , provided by the national medical cannabis advocacy organization Americans for Safe Access, admonishes current cannabis consumers: Medical cannabis patients and their providers are vulnerable to federal and state raids, arrest, prosecution, and incarceration. PERSONAL RIGHTS.

Cannabis 45

Cannabis Access Patients Legalization 45

Cannabis Law Report

AUGUST 24, 2019

In addition to banking obstacles in the cannabis business, there is a long trail ahead before there is unfettered banking access for cannabis patients. Consider Levine’s stark examples: “-Having a 10mg edible before going to sleep every night is not the same as smoking weed every day and neglecting one’s children.

Banking 49

Banking Marijuana Media Patients 49

Cannabis Law Report

JULY 30, 2019

Like others, Dr. Beasley is forced by default to expand her knowledge base through scientific facts that warrant closer inspection and through accessible existing research, with few current cannabis case studies. Patient and physician are on this rocky journey together, for better or worse. . through international sources, namely Israel. .

Marijuana 45

Marijuana Patients Research and Development Programs 45

Cannabis Law Report

MAY 14, 2022

Momentum Builds in Senate for Passing SAFE Act – Bipartisan support in the Senate grows for passage of the SAFE Banking Act, which would facilitate banking access for cannabis companies. Further, despite fears that recreational sales might threaten the supply for medicinal users, state data reveals that the medicinal market remained stable.

Banking 52

Banking Recreational Research and Development Cannabis 52